News phenox Inc. a Wallaby Medical Company, announces the FDA 510k Clearance of the pRESET® Thrombectomy Device for the treatment of acute ischemic stroke. English 2. February 2023 Wallaby/phenox announces global launch of the pEGASUS HPC Stent System – the first laser-cut, open-cell stent device with antithrombogenic HPC coating technology. 23. September 2022 Wallaby Expands Distribution Agreement With Japan Lifeline For Neurovascular Products for the Japan Market English 25. August 2022 Wallaby / phenox announces expansion of their global reach of pRESET thrombectomy devices at Global Stroke Alliance, Brazil. English 25. August 2022 Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion English 21. April 2022 Wallaby Medical und phenox schaffen ein weltweit führendes Unternehmen für neurovaskuläre Produkte – Zusammenschluss soll globales Wachstum beschleunigen German 21. April 2022 Largest real-world Flow Diverter study verifies safety and efficacy for phenox’ p64 Flow Modulation Device English 16. November 2021 phenox erhält zum sechsten Mal die Auszeichnung als Wachstumschampion German 5. November 2021 phenox announces the expansion of technology portfolio for AIS with the global launch of the pRESET® 6-50 thrombectomy device. English 14. October 2021 phenox is pleased to announce the results of a paper exploring the benefit of choosing a longer stentriever English 3. August 2021 Configuring 24-hour stroke thrombectomy services to save more patient lives English 9. June 2021 phenox expands even further with the opening of a new building at HQ English 21. May 2021 phenox expandiert weiter und eröffnet modernen Neubau im Technologie-Quartier Bochum German 17. May 2021 phenox GmbH expands with opening of new UK office English 10. February 2021 Results of the international Diversion-p64 study: The largest real-world Flow Diverter experience – Recording is available! English 30. November 2020 1 2 Next » Upcoming EventsCurrent MonthNo Upcoming Event
